Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SHSE:600645's Days Inventory is ranked worse than 55.02% of 638
companies
in the Biotechnology industry
Industry Median: 183.195
vs SHSE:600645: 201.83
Inventory Turnover measures how fast the company turns over its inventory within a year.
Zhongyuan Union Cell & Gene Engineering's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.42.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zhongyuan Union Cell & Gene Engineering's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.73.
Zhongyuan Union Cell & Gene Engineering (SHSE:600645) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Zhongyuan Union Cell & Gene Engineering's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zhongyuan Union Cell & Gene Engineering's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Zhongyuan Union Cell & Gene Engineering Days Inventory Related Terms
Zhongyuan Union Cell & Gene Engineering Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhongyuan Union Cell & Gene Engineering Days Inventory Chart
Zhongyuan Union Cell & Gene Engineering Annual Data
SHSE:600645 vs VRTX, REGN, ALNY: Days Inventory Comparison
For the Biotechnology subindustry, Zhongyuan Union Cell & Gene Engineering's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhongyuan Union Cell & Gene Engineering Days Inventory vs Biotechnology Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhongyuan Union Cell & Gene Engineering (SHSE:600645) has a Days Inventory of 218.23 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Zhongyuan Union Cell & Gene Engineering and its competitors. This is 25% above median its historical median of 173.99. Over the past decade, Zhongyuan Union Cell & Gene Engineering's Days Inventory has ranged from 77.47 to 201.83. According to the industry distribution chart, Zhongyuan Union Cell & Gene Engineering ranks #351 out of 638 companies in the Biotechnology industry, placing it in the top 55%.
Is Zhongyuan Union Cell & Gene Engineering's Days Inventory too high?
Zhongyuan Union Cell & Gene Engineering's current Days Inventory of 218.23 is 25% above median its 10-year median of 173.99. Over the past 10 years, this metric has ranged from a low of 77.47 to a high of 201.83. The Biotechnology industry median Days Inventory is 183.20. Zhongyuan Union Cell & Gene Engineering's value of 218.23 is 19.1% above this industry median. Based on the distribution chart, Zhongyuan Union Cell & Gene Engineering ranks #351 out of 638 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Zhongyuan Union Cell & Gene Engineering has a GF Score™ of 60/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhongyuan Union Cell & Gene Engineering's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Zhongyuan Union Cell & Gene Engineering ranks #351 out of 638 companies for Days Inventory. This places Zhongyuan Union Cell & Gene Engineering in the lower half of its industry. The industry median Days Inventory is 183.20. Zhongyuan Union Cell & Gene Engineering's value of 218.23 is 19.1% above this benchmark. Historically, Zhongyuan Union Cell & Gene Engineering's own Days Inventory has ranged from 77.47 to 201.83 over the past decade. While the company's 10-year median is 173.99 vs. the industry median of 183.20, Zhongyuan Union Cell & Gene Engineering has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhongyuan Union Cell & Gene Engineering's current Days Inventory of 218.23 is 19.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Zhongyuan Union Cell & Gene Engineering and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhongyuan Union Cell & Gene Engineering's current Days Inventory is 218.23, which is 25% above median its own 10-year median of 173.99. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhongyuan Union Cell & Gene Engineering stock overvalued right now?
Based on GuruFocus' analysis, Zhongyuan Union Cell & Gene Engineering (SHSE:600645) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥20.38, compared to a current price of ¥17.85 — trading 12.4% below its estimated fair value. The current Days Inventory is 218.23, which is 25% above median its 10-year median of 173.99 and 19.1% above the Biotechnology industry median of 183.20. Zhongyuan Union Cell & Gene Engineering's overall GF Score™ is 60/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Zhongyuan Union Cell & Gene Engineering (SHSE:600645), the current Days Inventory is 218.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhongyuan Union Cell & Gene Engineering (SHSE:600645) Overvalued in 2026?
Based on GuruFocus' analysis, Zhongyuan Union Cell & Gene Engineering stock appears to be undervalued.
The current stock price of ¥17.85 is trading 12.4% below its estimated GF Value™ of ¥20.38.
GuruFocus considers Zhongyuan Union Cell & Gene Engineering to be Modestly Undervalued.
Key valuation signals for SHSE:600645:
Days Inventory: 218.23 (25% above median its 10-year median of 173.99)
GF Value™: ¥20.38 vs. price of ¥17.85 (12.4% below fair value)
Industry Position: 19.1% above the Biotechnology median (#351 of 638)
No single metric tells the full story. See the SHSE:600645 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhongyuan Union Cell & Gene Engineering Business Description
Zhongyuan Union Cell & Gene Engineering Corp Ltd is engaged in stem cell technology research, as well as detection and storage sources of stem cells in China. The company insists on the core strategy upon dual-core development of 'cell + gene' with the major businesses covering various cell storage businesses of newborns and adults; the preparation and storage of cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, adipose-derived stem cells and immune cells; genetic testing services relating to children's genes.
60GF Score
Get the complete analysis for SHSE:600645
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600645 has been successfully added to your 
